# NLRP12

## Overview
NLRP12 is a gene that encodes the NLR family pyrin domain containing 12 protein, a member of the NOD-like receptor (NLR) family, which plays a pivotal role in the regulation of immune responses and inflammation. The NLRP12 protein is characterized by its multi-domain structure, including an N-terminal pyrin domain, a central nucleotide-binding domain, and C-terminal leucine-rich repeats, which facilitate its function as a molecular sensor and regulator within the immune system (Jin2016Crystal). It primarily acts as a negative regulator of the NF-κB signaling pathway, thereby maintaining immune homeostasis and preventing excessive inflammatory responses (Allen2012NLRP12). NLRP12 is predominantly expressed in myeloid lineage cells and is involved in various signaling pathways, including the MAPK pathway, influencing both innate and adaptive immunity (Tuncer2014The). Mutations in the NLRP12 gene are linked to autoinflammatory diseases, such as NLRP12-associated autoinflammatory disease, highlighting its clinical significance in immune regulation (Wang2022NLRP12associated).

## Structure
The NLRP12 protein is a member of the NOD-like receptor family and is characterized by a multi-domain structure. It contains an N-terminal pyrin domain (PYD), a central nucleotide-binding domain (NOD), and C-terminal leucine-rich repeats (LRRs) (Jin2016Crystal). The PYD is part of the death domain superfamily and is involved in protein-protein interactions, particularly in mediating homotypic and heterotypic interactions (Pinheiro2011The).

The PYD of NLRP12 adopts a typical six-helical bundle fold, which is a common feature of the death domain superfamily. This structure is stabilized by a conserved hydrophobic core (Pinheiro2011The). Notably, the NLRP12 PYD exhibits a unique structural feature where a two-amino-acid deletion in the α2-α3 loop results in the replacement of helix α3 with a 3_10 helix, contributing to increased flexibility in this region (Pinheiro2011The).

In terms of quaternary structure, the NLRP12 PYD can form a dimeric configuration through a disulfide bond, which may have biological significance in the context of reactive oxygen species-induced NF-κB activation (Jin2016Crystal). The protein also interacts with the UBA domain of the pro-apoptotic protein FAF-1, suggesting a role in linking innate immunity to apoptotic signaling (Pinheiro2011The).

## Function
NLRP12, a member of the NOD-like receptor (NLR) family, plays a crucial role in regulating inflammation and immune responses in healthy human cells. It primarily functions as a negative regulator of the NF-κB signaling pathway, which is essential for controlling inflammatory responses. NLRP12 achieves this by interacting with key signaling molecules such as NF-κB-inducing kinase (NIK) and tumor necrosis factor receptor-associated factor 3 (TRAF3), leading to the degradation of NIK and suppression of noncanonical NF-κB activation (Allen2012NLRP12; Zhang2020Nucleotide). This regulation helps maintain immune homeostasis and prevents excessive inflammation, which can lead to tissue damage and disease (Allen2012NLRP12).

In addition to its role in NF-κB signaling, NLRP12 is involved in the modulation of other signaling pathways, such as the MAPK pathway, and plays a role in adaptive immunity by influencing the migration of dendritic cells and neutrophils (Allen2012NLRP12; Tuncer2014The). NLRP12 is primarily expressed in myeloid lineage cells, including neutrophils, eosinophils, monocytes, macrophages, and immature dendritic cells, where it acts as a molecular sensor to detect pathogen-associated molecular patterns and danger signals (Papale2016Understanding; Tuncer2014The).

## Clinical Significance
Mutations in the NLRP12 gene are associated with several autoinflammatory diseases, most notably NLRP12-associated autoinflammatory disease (NLRP12-AID), also known as familial cold autoinflammatory syndrome 2 (FCAS2). This condition is characterized by periodic fever, multisystem inflammatory damage, and symptoms such as polyarthralgia, abdominal pain, rash, and elevated acute-phase reactants. It primarily affects children and is triggered by cold exposure (Wang2022NLRP12associated).

The NLRP12 gene mutations can lead to either loss-of-function or gain-of-function effects, impacting the regulation of inflammatory pathways. For instance, the R352C mutation is associated with enhanced caspase 1 processing, indicating a gain-of-function mutation that contributes to the inflammatory phenotype (Yun2024Genetic; Jéru2011Identification). The F402L variant, although prevalent in healthy controls, is frequently reported in patients and is considered potentially pathogenic (Del2020NLRP12).

NLRP12 mutations can also result in hereditary periodic fever syndromes, with symptoms overlapping those of familial cold autoinflammatory syndrome and Muckle-Wells syndrome. These mutations often lead to a loss of function in the NLRP12 protein, reducing its ability to inhibit NF-κB signaling, a key pathway in inflammation (Jéru2008Mutations). The clinical presentation of NLRP12-related conditions is highly variable, with some patients exhibiting autoimmune symptoms and a history of allergies (Miao2023NLRP12associated).

## Interactions
NLRP12 interacts with several proteins, playing a significant role in immune regulation and signaling pathways. It interacts with TRIM25, an E3 ubiquitin ligase, to disrupt the association between RIG-I and TRIM25, reducing TRIM25-mediated Lys63-linked ubiquitination of RIG-I. This interaction negatively regulates RIG-I-mediated IFN-β production, which is crucial for antiviral responses (Chen2019NLRP12).

NLRP12 also interacts with CUL3, a component of ubiquitin ligase complexes, which may influence NF-κB signaling. This interaction was confirmed in HEK 293T cells using co-immunoprecipitation and western blotting, suggesting a regulatory role in inflammatory responses (Rippe2022Examining).

In the context of colorectal cancer, NLRP12 interacts with STK38 to inhibit the phosphorylation of GSK3β, leading to the degradation of β-catenin. This interaction suppresses the Wnt/β-catenin signaling pathway, which is crucial for colorectal cancer progression (Khan2023NLRP12).

Additionally, NLRP12's pyrin domain interacts with FAF-1, with specific residues on the α2-α3 surface of NLRP12 PYD mediating this binding. This interaction is characterized by hydrophobic contacts, particularly involving Trp45 (Pinheiro2011The).


## References


[1. (Yun2024Genetic) Mark Yun, Zuoming Deng, Brianne Navetta-Modrov, Baozhong Xin, Jie Yang, Hafsa Nomani, Olga Aroniadis, Peter D. Gorevic, and Qingping Yao. Genetic variations in nlrp3 and nlrp12 genes in adult-onset patients with autoinflammatory diseases: a comparative study. Frontiers in Immunology, January 2024. URL: http://dx.doi.org/10.3389/fimmu.2023.1321370, doi:10.3389/fimmu.2023.1321370. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2023.1321370)

[2. (Zhang2020Nucleotide) Yue Zhang and Curtis T. Okamoto. Nucleotide binding domain and leucine-rich repeat pyrin domain-containing protein 12: characterization of its binding to hematopoietic cell kinase. International Journal of Biological Sciences, 16(9):1507–1525, 2020. URL: http://dx.doi.org/10.7150/ijbs.41798, doi:10.7150/ijbs.41798. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.7150/ijbs.41798)

[3. (Jin2016Crystal) T. Jin, M. Huang, J. Jiang, and T. Xiao. Crystal structure of human nlrp12 pyd domain and implication in homotypic interaction. January 2016. URL: http://dx.doi.org/10.2210/pdb4xhs/pdb, doi:10.2210/pdb4xhs/pdb. This article has 0 citations.](https://doi.org/10.2210/pdb4xhs/pdb)

[4. (Papale2016Understanding) Angela Papale, Elena Kummer, Valentina Galbiati, Marina Marinovich, Corrado L. Galli, and Emanuela Corsini. Understanding chemical allergen potency: role of nlrp12 and blimp-1 in the induction of il-18 in human keratinocytes. Archives of Toxicology, 91(4):1783–1794, September 2016. URL: http://dx.doi.org/10.1007/s00204-016-1806-8, doi:10.1007/s00204-016-1806-8. This article has 9 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1007/s00204-016-1806-8)

[5. (Chen2019NLRP12) Szu-Ting Chen, Liang Chen, Diego Shih-Chieh Lin, Sei-Yi Chen, Yen-Po Tsao, Haitao Guo, Fei-Ju Li, Wei-Ting Tseng, Jason W. Tam, Chih-Wei Chao, W. June Brickey, Ivan Dzhagalov, Moon-Jung Song, Hye-Ri Kang, Jae U. Jung, and Jenny P.-Y. Ting. Nlrp12 regulates anti-viral rig-i activation via interaction with trim25. Cell Host &amp; Microbe, 25(4):602-616.e7, April 2019. URL: http://dx.doi.org/10.1016/j.chom.2019.02.013, doi:10.1016/j.chom.2019.02.013. This article has 72 citations.](https://doi.org/10.1016/j.chom.2019.02.013)

[6. (Rippe2022Examining) Catherine A Rippe. Examining the immune regulatory function of nlrp12 through novel protein interactions. The Journal of Immunology, 208(1_Supplement):50.28-50.28, May 2022. URL: http://dx.doi.org/10.4049/jimmunol.208.supp.50.28, doi:10.4049/jimmunol.208.supp.50.28. This article has 0 citations.](https://doi.org/10.4049/jimmunol.208.supp.50.28)

[7. (Miao2023NLRP12associated) Junke Miao, Jingyuan Zhang, Xin Huang, Na Wu, Di Wu, and Min Shen. Nlrp12-associated autoinflammatory disease in chinese adult patients: a single-centre study. RMD Open, 9(4):e003598, December 2023. URL: http://dx.doi.org/10.1136/rmdopen-2023-003598, doi:10.1136/rmdopen-2023-003598. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1136/rmdopen-2023-003598)

[8. (Del2020NLRP12) Flavia Del Porto, Noemi Cifani, Maria Proietta, Elena Verrecchia, Roberta Di Rosa, Raffaele Manna, and Pietro Chiurazzi. Nlrp12 gene mutations and auto-inflammatory diseases: ever-changing evidence. Rheumatology, 59(11):3129–3136, July 2020. URL: http://dx.doi.org/10.1093/rheumatology/keaa304, doi:10.1093/rheumatology/keaa304. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/rheumatology/keaa304)

[9. (Allen2012NLRP12) Irving C. Allen, Justin E. Wilson, Monika Schneider, John D. Lich, Reid A. Roberts, Janelle C. Arthur, Rita-Marie T. Woodford, Beckley K. Davis, Joshua M. Uronis, Hans H. Herfarth, Christian Jobin, Arlin B. Rogers, and Jenny P.-Y. Ting. Nlrp12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical nf-κb signaling. Immunity, 36(5):742–754, May 2012. URL: http://dx.doi.org/10.1016/j.immuni.2012.03.012, doi:10.1016/j.immuni.2012.03.012. This article has 408 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.immuni.2012.03.012)

[10. (Tuncer2014The) Sinem Tuncer, Maria Teresa Fiorillo, and Rosa Sorrentino. The multifaceted nature of nlrp12. Journal of Leukocyte Biology, 96(6):991–1000, September 2014. URL: http://dx.doi.org/10.1189/jlb.3ru0514-265rr, doi:10.1189/jlb.3ru0514-265rr. This article has 57 citations and is from a peer-reviewed journal.](https://doi.org/10.1189/jlb.3ru0514-265rr)

[11. (Wang2022NLRP12associated) Hui-fang Wang. Nlrp12-associated systemic autoinflammatory diseases in children. Pediatric Rheumatology, February 2022. URL: http://dx.doi.org/10.1186/s12969-022-00669-8, doi:10.1186/s12969-022-00669-8. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12969-022-00669-8)

[12. (Jéru2011Identification) Isabelle Jéru, Gaëlle Le Borgne, Emmanuelle Cochet, Hasmik Hayrapetyan, Philippe Duquesnoy, Gilles Grateau, Alain Morali, Tamara Sarkisian, and Serge Amselem. Identification and functional consequences of a recurrent nlrp12 missense mutation in periodic fever syndromes. Arthritis &amp; Rheumatism, 63(5):1459–1464, April 2011. URL: http://dx.doi.org/10.1002/art.30241, doi:10.1002/art.30241. This article has 84 citations.](https://doi.org/10.1002/art.30241)

[13. (Khan2023NLRP12) Shahanshah Khan, Youn-Tae Kwak, Lan Peng, Shuiqing Hu, Brandi L. Cantarel, Cheryl M. Lewis, Yunpeng Gao, Ram S. Mani, Thirumala-Devi Kanneganti, and Hasan Zaki. Nlrp12 downregulates the wnt/β-catenin pathway via interaction with stk38 to suppress colorectal cancer. Journal of Clinical Investigation, October 2023. URL: http://dx.doi.org/10.1172/jci166295, doi:10.1172/jci166295. This article has 10 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci166295)

[14. (Pinheiro2011The) Anderson S. Pinheiro, Clarissa Eibl, Zeynep Ekman-Vural, Robert Schwarzenbacher, and Wolfgang Peti. The nlrp12 pyrin domain: structure, dynamics, and functional insights. Journal of Molecular Biology, 413(4):790–803, November 2011. URL: http://dx.doi.org/10.1016/j.jmb.2011.09.024, doi:10.1016/j.jmb.2011.09.024. This article has 54 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jmb.2011.09.024)

[15. (Jéru2008Mutations) I. Jéru, P. Duquesnoy, T. Fernandes-Alnemri, E. Cochet, J. W. Yu, M. Lackmy-Port-Lis, E. Grimprel, J. Landman-Parker, V. Hentgen, S. Marlin, K. McElreavey, T. Sarkisian, G. Grateau, E. S. Alnemri, and S. Amselem. Mutations in nalp12 cause hereditary periodic fever syndromes. Proceedings of the National Academy of Sciences, 105(5):1614–1619, February 2008. URL: http://dx.doi.org/10.1073/pnas.0708616105, doi:10.1073/pnas.0708616105. This article has 300 citations.](https://doi.org/10.1073/pnas.0708616105)